VBI Vaccines Inc., of Cambridge, Mass., said the Meghan Rose Bradley Foundation, a pediatric brain cancer advocacy organization, is providing a grant to support initial research of the company's immunotherapy candidate in ex vivo studies using medulloblastoma patient samples.